Helix BioPharma Corp. (HBP:TSX) closed at $0.980 on October 16, 2026, up 7.69% on the day. The stock trades 64.4% below its 52-week high of $2.75 and 15.3% above its 52-week low of $0.850. Over the past year, it lost 54.0%. Helix BioPharma Corp. is part of the Life Sciences sector (Biotechnology).
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| +2.08% | -30.00% | -31.47% | -50.00% | -53.99% |
In 252 trading sessions since October 16, 2025, HBP closed higher on 103 days (41%). Its best day was January 23, 2026 (+14.75%) and its worst was May 7, 2026 (-19.61%). The stock moved 10% or more in a single session 14 times. It opened at least 5% above the previous day's high 10 times.
Helix BioPharma Corp is a biopharmaceutical company mainly focused in the field of cancer therapy. The Company is actively developing products for the treatment and prevention of cancer based on its proprietary technologies.
Find more stocks like HBP with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.